Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation

Traditional antithrombotic agents commonly share a therapy-limiting side effect, as they increase the overall systemic bleeding risk. A novel approach for targeted antithrombotic therapy is nanoparticles. In other therapeutic fields, nanoparticles have enabled site-specific delivery with low levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Nestele, Jeremy A., Rohlfing, Anne-Katrin, Dicenta, Valerie, Bild, Alexander, Eißler, Daniela, Emschermann, Frederic, Kremser, Marcel, Krutzke, Konstantin, Schäffer, Tilman E., Borst, Oliver, Levi, Moran, Korin, Netanel, Gawaz, Meinrad Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744670/
https://www.ncbi.nlm.nih.gov/pubmed/35008437
http://dx.doi.org/10.3390/ijms23010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744670/
https://www.ncbi.nlm.nih.gov/pubmed/35008437
http://dx.doi.org/10.3390/ijms23010011

Ejemplares similares